Difference between revisions of "Template:Lipid modifying agents"

From blackwiki
Jump to navigation Jump to search
imported>DSisyphBot
m (r2.5.1) (Robot: Adding fr:Modèle:Palette Statine)
imported>Anypodetos
 
(41 intermediate revisions by 21 users not shown)
Line 1: Line 1:
 
{{Navbox
 
{{Navbox
| name = Lipid modifying agents
+
| name = Lipid modifying agents
| title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]])
+
| title = [[Hypolipidemic agent|Lipid-modifying agents]] ([[ATC code C10|C10]])
|listclass = hlist
+
| state = {{{state<includeonly>|autocollapse</includeonly>}}}
| groupstyle = background:MistyRose;
+
| listclass = hlist
  
| group1 = [[GI tract]]
+
| group1 = [[Human gastrointestinal tract|GI tract]]
| list1 = {{Navbox subgroup
+
| list1 = {{Navbox|child
| groupstyle = background:MistyRose;
 
  
| group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]]
+
  | group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]]
| list1 =
+
  | list1 =
 
* [[Ezetimibe]]
 
* [[Ezetimibe]]
 
* [[SCH-48461]]
 
* [[SCH-48461]]
  
| group2 = [[Bile acid sequestrant]]s/[[Ion exchange resin|resins]] ([[Low-density lipoprotein|LDL]])
+
  | group2 = [[Bile acid sequestrant]]s/[[Ion-exchange resin|resins]] ([[Low-density lipoprotein|LDL]])
| list2 =
+
  | list2 =
* [[Cholestyramine]]
+
* [[Colesevelam]]
 +
* [[Colestilan]]
 
* [[Colestipol]]
 
* [[Colestipol]]
* [[Colestilan]]
+
* [[Colestyramine]]
 
* [[Colextran]]
 
* [[Colextran]]
* [[Colesevelam]]
 
  
}}
+
}}
  
 +
| group2 = [[Liver]]
 +
| list2 = {{Navbox|child
  
| group2 = [[Liver]]
+
  | group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]])
|  list2 = {{Navbox subgroup
+
  | list1 =
| groupstyle = background:MistyRose;
 
 
 
| group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]])
 
| list1 =
 
* [[Simvastatin]]<sup>#</sup>
 
 
* [[Atorvastatin]]
 
* [[Atorvastatin]]
 +
* [[Cerivastatin]]<sup>‡</sup>
 
* [[Fluvastatin]]
 
* [[Fluvastatin]]
 
* [[Lovastatin]]
 
* [[Lovastatin]]
Line 39: Line 36:
 
* [[Pravastatin]]
 
* [[Pravastatin]]
 
* [[Rosuvastatin]]
 
* [[Rosuvastatin]]
* [[Cerivastatin]]<sup></sup>
+
* [[Simvastatin]]<sup>#</sup>
  
| group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]])
+
  | group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]])
| list2 =
+
  | list2 =
 +
* [[Acipimox]]
 +
* [[Aluminium nicotinate]]
 +
* [[Niacin]]
 
* [[Niceritrol]]
 
* [[Niceritrol]]
* [[Niacin]]
 
 
* [[Nicofuranose]]
 
* [[Nicofuranose]]
* [[Aluminium nicotinate]]
 
 
* [[Nicotinyl alcohol]]
 
* [[Nicotinyl alcohol]]
* [[Acipimox]]
 
  
}}
+
  | group3 = [[Microsomal triglyceride transfer protein|MTTP]] inhibitors ([[Very low-density lipoprotein|VLDL]])
 +
  | list3 =
 +
* [[Dirlotapide]]
 +
* [[Lomitapide]]
 +
* [[Mitratapide]]
 +
 
 +
  | group4 = [[ATP citrate lyase]] inhibitors ([[Low-density lipoprotein|LDL]])
 +
  | list4 =
 +
* [[Bempedoic acid]]
 +
 
 +
}}
  
| group4 = [[Blood vessel]]s
+
| group3 = [[Blood vessel]]s
| list4 = {{Navbox subgroup
+
| list3 = {{Navbox|child
| groupstyle = background:MistyRose;
+
  | evenodd = swap
  
| group1 =   [[Fibrate]]s ([[PPAR modulator|PPAR]])
+
  | group1 = [[Fibrate]]s ([[PPAR agonist|PPAR]])
| list1 =
+
  | list1 =
 +
* [[Aluminium clofibrate]]
 +
* [[Bezafibrate]]
 +
* [[Choline fenofibrate]]
 +
* [[Ciprofibrate]]
 +
* [[Clinofibrate]]
 
* [[Clofibrate]]<sup>‡</sup>
 
* [[Clofibrate]]<sup>‡</sup>
* [[Bezafibrate]]
+
* [[Clofibride]]
* [[Aluminium clofibrate]]
+
* [[Etofibrate]]
 +
* [[Fenofibrate]]
 
* [[Gemfibrozil]]
 
* [[Gemfibrozil]]
* [[Fenofibrate]]
+
* [[Pemafibrate]]
 +
* [[Ronifibrate]]
 
* [[Simfibrate]]
 
* [[Simfibrate]]
* [[Ronifibrate]]
 
* [[Ciprofibrate]]
 
* [[Etofibrate]]
 
* [[Clofibride]]
 
* [[Clinofibrate]]
 
 
  
| group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]])
+
  | group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]])
| list2 =
+
  | list2 =
 
* [[Anacetrapib]]<sup>†</sup>
 
* [[Anacetrapib]]<sup>†</sup>
* [[Dalcetrapib]]
+
* [[Dalcetrapib]]<sup>§</sup>
* [[Evacetrapib]]
+
* [[Evacetrapib]]<sup>§</sup>
 +
* [[Obicetrapib]]<sup>†</sup>
 
* [[Torcetrapib]]<sup>§</sup>
 
* [[Torcetrapib]]<sup>§</sup>
  
 +
  | group3 = [[PCSK9 inhibitor]]s ([[Low-density lipoprotein|LDL]])
 +
  | list3 =
 +
* [[Alirocumab]]
 +
* [[Bococizumab]]
 +
* [[Evolocumab]]
  
 +
}}
  
}}
+
| group4 = Combinations
 
+
| list4 =
 
+
* [[Amlodipine/atorvastatin]]
| group7 = Combinations
+
* [[Bempedoic acid/ezetimibe]]
| list7 =
+
* [[Ezetimibe/atorvastatin]]
 +
* [[Ezetimibe/rosuvastatin]]
 +
* [[Ezetimibe/simvastatin]]
 +
* [[Fenofibrate/pravastatin]]
 +
* [[Fenofibrate/simvastatin]]
 +
* [[Laropiprant|Niacin/laropiprant]]
 
* [[Niacin/lovastatin]]
 
* [[Niacin/lovastatin]]
 
* [[Niacin/simvastatin]]
 
* [[Niacin/simvastatin]]
* [[Ezetimibe/simvastatin]]
 
* [[Laropiprant|Niacin/laropiprant]]
 
  
| group8 = Other
+
| group5 = Other
| list8 =
+
| list5 =
* [[Dextrothyroxine]]
+
* [[Alipogene tiparvovec]]
* [[Probucol]]
+
* [[Azacosterol]]
* [[Tiadenol]]
+
* [[Azalanstat]]
* [[Benfluorex]]
+
* [[Benfluorex]]<sup>‡</sup>
 +
* [[Darapladib]]<sup>§</sup>
 +
* [[Dextrothyroxine]]<sup>‡</sup>
 +
* [[Inclisiran]]
 +
* [[Lapaquistat]]<sup>§</sup>
 +
* [[Magnesium pyridoxal 5-phosphate glutamate]]
 
* [[Meglutol]]
 
* [[Meglutol]]
 +
* [[Mipomersen]]
 
* [[Omega-3-triglycerides]]
 
* [[Omega-3-triglycerides]]
* [[Magnesium pyridoxal 5-phosphate glutamate]]
 
 
* [[Policosanol]]
 
* [[Policosanol]]
* [[Lapaquistat]]<sup>§</sup>
+
* [[Probucol]]
* [[Mipomersen]]
+
* [[Tiadenol]]
* [[Alipogene tiparvovec]]
+
* [[Triparanol]]<sup></sup>
 +
* [[Volanesorsen]]
  
| list9 = {{PharmNavFootnote}}
+
| list6 = {{PharmNavFootnote}}
 
 
| belowstyle = background: transparent; padding: 0px;
 
| below = {{Metabolic navs}}
 
  
 
}}<noinclude>
 
}}<noinclude>
 
+
{{collapsible option}}
[[Category:Drug_templates by ATC]]
+
[[Category:Drug templates by ATC]]
[[fr:Modèle:Palette Statine]]
 
[[pt:Predefinição:Hipolipemiantes]]
 
 
</noinclude>
 
</noinclude>

Latest revision as of 14:49, 3 January 2021

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Lipid modifying agents|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Lipid modifying agents|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Lipid modifying agents|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.